skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Mamu-A*01/K{sup b} transgenic and MHC Class I knockout mice as a tool for HIV vaccine development

Journal Article · · Virology
OSTI ID:21357503
; ; ;  [1];  [2];  [3]; ; ;  [1];  [4];  [1];  [5]
  1. Division of Translational Vaccine Research, Fox South, 1000B, Beckman Research Institute of the City of Hope, 1500 E. Duarte Rd., Comprehensive Cancer Center, Duarte, CA 91010 (United States)
  2. Animal Resource Center, City of Hope Comprehensive Cancer Center, Duarte, CA (United States)
  3. Transgenic Mouse Core Facility, City of Hope Comprehensive Cancer Center, Duarte, CA (United States)
  4. Department of Pathology and Laboratory Medicine, University of California, Davis, CA (United States)
  5. Beckman Research Institute of the City of Hope, Division of Information Sciences, City of Hope Comprehensive Cancer Center, Duarte, CA (United States)

We have developed a murine model expressing the rhesus macaque (RM) Mamu-A*01 MHC allele to characterize immune responses and vaccines based on antigens of importance to human disease processes. Towards that goal, transgenic (Tg) mice expressing chimeric RM (alpha1 and alpha2 Mamu-A*01 domains) and murine (alpha3, transmembrane, and cytoplasmic H-2K{sup b} domains) MHC Class I molecules were derived by transgenesis of the H-2K{sup b}D{sup b} double MHC Class I knockout strain. After immunization of Mamu-A*01/K{sup b} Tg mice with rVV-SIVGag-Pol, the mice generated CD8{sup +} T-cell IFN-gamma responses to several known Mamu-A*01 restricted epitopes from the SIV Gag and Pol antigen sequence. Fusion peptides of highly recognized CTL epitopes from SIV Pol and Gag and a strong T-help epitope were shown to be immunogenic and capable of limiting an rVV-SIVGag-Pol challenge. Mamu-A*01/K{sup b} Tg mice provide a model system to study the Mamu-A*01 restricted T-cell response for various infectious diseases which are applicable to a study in RM.

OSTI ID:
21357503
Journal Information:
Virology, Vol. 387, Issue 1; Other Information: DOI: 10.1016/j.virol.2009.01.041; PII: S0042-6822(09)00074-9; Copyright (c) 2009 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.; ISSN 0042-6822
Country of Publication:
United States
Language:
English